Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.7900 (-0.42%) ($100.1550 - $103.3000) on Tue. Sep. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.8% (three month average) | RSI | 29 | Latest Price | $101.7900(-0.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -5.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(49%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.4% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.4% (StdDev 2.8%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $96.4(-5.3%) | Resistance Level | $110.89 | 5 Day Moving Average | $103.12(-1.29%) | 10 Day Moving Average | $107.04(-4.9%) | 20 Day Moving Average | $110.89(-8.21%) | To recent high | -19.7% | To recent low | 0% | Market Cap | $1.636b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |